Gene-Editing shot aims to halt rare nerve disease in phase 3 trial

NCT ID NCT06672237

First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 23 times

Summary

This study tests a single dose of NTLA-2001, a gene-editing therapy, in 60 adults with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a genetic disease that damages nerves. The goal is to see if the treatment can stop or slow the disease by lowering a harmful protein. Participants are randomly assigned to receive the drug or a placebo, and neither they nor their doctors will know which they received.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chang Gung Medical Foundation - Linkou Branch

    ACTIVE_NOT_RECRUITING

    Taoyuan, Taiwan

  • HCFMRP - Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto

    RECRUITING

    Ribeirão Preto, Brazil

  • Hospital Británico de Buenos Aires

    RECRUITING

    Buenos Aires, Argentina

  • Hospital El Cruce

    RECRUITING

    San Juan Bautista, Argentina

  • Hospital Italiano de Buenos Aires (HIBA)

    RECRUITING

    Buenos Aires, Argentina

  • Hospital das Clinicas da Universidade Estadual de Campinas (UNICAMP)

    RECRUITING

    Campinas, Brazil

  • Instituto de Educacao, Pesquisa e Gestao em Saude

    RECRUITING

    Rio de Janeiro, Brazil

  • National Institute of Medical Sciences and Nutrition - Salvador Zubiran (INCMNSZ)

    RECRUITING

    Tlalpan, Mexico

  • National Taiwan University Hospital

    ACTIVE_NOT_RECRUITING

    Taipei, Taiwan

  • National University Hospital

    RECRUITING

    Singapore, Singapore

  • PSEG Centro de Pesquisa Clinica S.A.

    RECRUITING

    São Paulo, Brazil

  • Singapore General Hospital

    RECRUITING

    Singapore, Singapore

  • Siriraj Hospital

    RECRUITING

    Bangkok, Thailand

  • Taipei Veterans General Hospital

    ACTIVE_NOT_RECRUITING

    Taipei, Taiwan

Conditions

Explore the condition pages connected to this study.